Eli Lilly and Company (FRA:LLY)
Germany · Delayed Price · Currency is EUR 917.70
-6.20 (-0.67%)
At close: Dec 1, 2025
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
€1,077,521
Profits / Employee
€333,886
Market Cap
814.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Eli Lilly and Company News
- 17 hours ago - Eli Lilly (LLY) Reduces Zepbound Prices on Direct Platform - GuruFocus
- 17 hours ago - Eli Lilly Lowers Weight-Loss Drug Zepbound Prices After Trump Deal - Forbes
- 18 hours ago - Eli Lilly (LLY) Reduces Zepbound Prices Amid Rising Demand for Obesity Treatments - GuruFocus
- 18 hours ago - Eli Lilly lowers starting dose costs for Zepbound on direct purchase platform - Seeking Alpha
- 19 hours ago - Eli Lilly's price cut, Thanksgiving box office, trouble for gravestone makers and more in Morning Squawk - CNBC
- 19 hours ago - Eli Lilly cuts Zepbound price to widen access for obesity drug - Reuters
- 19 hours ago - Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site - CNBC
- 19 hours ago - Eli Lilly (LLY) Sets Tender Offer to Acquire Adverum Biotechnologies - GuruFocus